CutPRO® Cut Resistant Clothing Sponsoring Leading Glass Event ‘Glass Focus 2019’
19.11.2019 11:00:00 EET | Business Wire | Press release
British firm CutPRO® is sponsoring this year’s ‘Glass Focus 2019’ event taking place on 21 November in Sheffield, United Kingdom.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191119005029/en/
CutPRO® is a pioneering British brand of high performance cut resistant clothing, providing fully CE certified, EN 388:2016 tested and thoroughly field tested cut protection. (Graphic: Business Wire)
Robert Kaiser, CEO of PPSS Group, the firm behind the CutPRO® brand, also announced it had entered the ‘Health and Safety Action’ category: “We have high hopes to win this prestigious award. Our innovative and pioneering brand of high performance cut resistant clothing somewhat deserves that level of recognition”.
The event is organised by ‘British Glass’, the representative body for the UK industry. Communicating the glass sector’s values and interests, their aim is to secure a thriving and sustainable future.
UK based PPSS Group has been producing cut resistant clothing for the past ten years, its sole purpose being the protection of frontline professionals in sectors where cuts and lacerations are a high risk e.g. homeland security.
In February 2018 the now highly acclaimed CutPRO® brand was launched, again using their very own Cut-Tex® PRO cut resistant fabric. Cut-Tex® PRO has achieved outstanding levels of cut, tear, abrasion and puncture resistance, while being extremely durable, lightweight and rather comfortable.
As a single layer it is offering ANSI/ISEA 2016 Blade Cut Resistance Level A5.
CutPRO®s Senior Product Consultant Eve Ichim operated as a liaison between potential customers and the firm’s production team, gathering relevant information about precise requirements and preferences for cut resistant clothing.
Based on this information, extensive market research and working together with the multi-award-winning Department of Apparel from one UK’s leading Universities, CutPRO® is now offering the ultimate garment designs, taking 'durability' and 'quality' to a completely different level.
All garments are manufactured in the E.U. and are fully CE marked and certified (Cat II PPE). This means they fully comply with European laws, rules and regulations.
All garments have also been successful assessed against the updated and latest EN 388:2016 standard, confirming the following performance levels: Cut Resistance Level E (Level 5 on previous standard). Puncture Resistance Level 4. Tear Resistance Level 4. Abrasion Resistance Level 3.
If you are planning to attend the ‘Glass Focus 2019’ go and say hi to their team. You will be welcomed with open arms and an immense level of technical knowledge.
Robert Kaiser has also recently announced his company’s participation at next year’s glasstec2020 Expo in Dusseldorf, Germany:
"We have decided to present and exhibit our truly outstanding cut resistant clothing range at glasstec2020, the world’s largest and most respected Exhibition within the glass industry."
"There is no better platform for us to showcase our range of potentially lifesaving cut resistant garments to the world."
In case you have any questions in reference to cut resistant clothing, please email info@cut-pro.com or visit www.cut-pro.com.
END
About CutPRO®
CutPRO® Cut Resistant Clothing is a pioneering brand of highly protective clothing. Made from the world’s most reliable, fully certified and thoroughly field-tested cut resistant fabric Cut-Tex® PRO. The company’s social media presence: Facebook, LinkedIn, Twitter and Instagram.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20191119005029/en/
Contact information
Ryan Vickers, CDO
PPSS Group / CutPRO®
info@ppss-group.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Takeda Receives U.S. FDA Approval of MIMRYLO™ (rusfertide), Marking a Potential Shift in the Treatment Paradigm for Polycythemia Vera29.8.2026 01:40:00 EEST | Press release
Takeda (TSE:4502/NYSE:TAK)announced U.S. Food and Drug Administration (FDA) approval of the New Drug Application (NDA)* for MIMRYLO™ (rusfertide) for the treatment of erythrocytosis in adults with polycythemia vera (PV), a blood cancer. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260824773270/en/ MIMRYLO Logo MIMRYLO is a first-in-class hepcidin mimetic designed to regulate iron distribution in the body and red blood cell overproduction to control hematocrit levels, which is the ratio of red blood cells to the total amount of blood in the body. Maintaining controlled hematocrit levels below 45% is the primary treatment goal in PV.1 “For patients living with PV, uncontrolled hematocrit can have serious consequences, including an elevated risk of life-threatening thrombotic events," said Andrew T. Kuykendall, M.D., VERIFY lead investigator and Associate Member in the Department of Hematology at Moffitt Cancer Center. “Curre
Rigaku and Tohoku University Establish a New Research Institute for X-Ray Metrology28.8.2026 17:00:00 EEST | Press release
Rigaku Corporation, a group company of Rigaku Holdings and a global solutions partner for X-ray analytical systems (Head Office: Akishima, Tokyo; President and CEO: Jun Kawakami; “Rigaku”), and Tohoku University (Sendai, Miyagi; President: Teiji Tominaga; “Tohoku University”) have established the Rigaku-Tohoku University Co-Creation Research Institute for X-ray Metrology: Beyond The Limits (the “Institute”) at Tohoku University on August 1, 2026. The Institute will advance X-ray metrology technology, develop new metrology methods, and foster the next generation of researchers through an initial three-year collaboration, with the possibility of extension based on its achievements. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260828688510/en/ Inside the Institute As semiconductors become smaller, more multilayered, and incorporate a wider range of materials, manufacturing processes are becoming increasingly complex. X-ray me
BLK: Portfolio Company of Enry’s Island S.p.A., Lists on Euronext Dublin28.8.2026 16:34:00 EEST | Press release
Enry’s Island S.p.A. (WBAG:EIOS), an international venture builder with headquarters in the Tremiti Islands and the Metaverse, announces that BLK Global PLC, one of the portfolio companies within its ecosystem, has successfully completed its admission to trading on Euronext Access Dublin. Trading in the company’s shares commenced on Friday, July 31, 2026, under ticker BLKX and ISIN GB00BPSKS130. BLK was one of the thousands of applications received by Enry’s Island which, following an assessment process based on the Enry’s Model, was selected for a one-year incubation and acceleration programme. The programme supported the company through its subsequent growth stages, ultimately leading to its current stock market listing. Alessandro Pacciana, Investor Relations Manager of Enry’s Island S.p.A., said: “BLK’s listing is the second stock market listing in two years among Enry’s Island’s portfolio companies, while Enry’s Island itself is the world’s first listed venture builder. We are pro
Zambon Announces European Commission Approval of Hopledo® for Adults with Parkinson's Disease and Moderate to Severe Motor Fluctuations28.8.2026 12:00:00 EEST | Press release
Zambon today announced that the European Commission (EC) has granted marketing authorization for Hopledo® (modified-release levodopa/carbidopa) for the treatment of adult patients with Parkinson’s disease and moderate to severe motor fluctuations who have not been sufficiently stabilized with oral levodopa/dopa decarboxylase (DDC) inhibitor-based treatment regimens. Zambon expects to begin the phased introduction of Hopledo® across European markets starting October 2026. The company is working closely with healthcare authorities and other stakeholders to support timely access for people with Parkinson’s disease who continue to experience moderate to severe motor fluctuations despite current oral therapies. Hopledo® is a first-in-class, oral, modified-release formulation of levodopa/carbidopa (LD/CD) approved for the treatment of motor fluctuations of Parkinson’s disease, the fastest growing neurological condition in the world according to the World Health Organization1. Despite availab
MTG-I2 Safely in Orbit, Unlocking Faster and Sharper Weather Monitoring Across Europe28.8.2026 11:16:00 EEST | Press release
The Meteosat Third Generation Imager 2 satellite (MTG-I2) has successfully passed its first critical post-launch milestones, completing the first full Meteosat Third Generation constellation in orbit. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260828243790/en/ Credit: Arianespace livestream The imager satellite MTG-I2 is safely in orbit and operating as expected following its successful launch yesterday at 22:11 CEST on board an Ariane 6 rocket from Europe’s Spaceport in French Guiana. Our teams have established communication with the spacecraft, which has also deployed its solar panels to ensure its autonomous production of energy. MTG-I2 is in perfect shape to start its Launch and Early Operations Phase that will bring it to a higher orbit, 36 000km above Earth over the following two weeks, where a longer period of calibration and validation of its instruments will begin. This summer’s extreme weather and wildfires hav
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom